Tara Bancroft
Stock Analyst at TD Cowen
(2.19)
# 2,800
Out of 5,114 analysts
10
Total ratings
62.5%
Success rate
6.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DAWN Day One Biopharmaceuticals | Initiates: Buy | $34 | $11.16 | +204.66% | 1 | Jan 13, 2026 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $9.95 | +101.01% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $66.68 | +19.98% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $30.00 | +66.67% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $79.73 | -18.47% | 1 | Sep 24, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.37 | +629.93% | 1 | Apr 29, 2024 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $6.52 | - | 1 | Aug 31, 2022 |
Day One Biopharmaceuticals
Jan 13, 2026
Initiates: Buy
Price Target: $34
Current: $11.16
Upside: +204.66%
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $9.95
Upside: +101.01%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $66.68
Upside: +19.98%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $30.00
Upside: +66.67%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $79.73
Upside: -18.47%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.37
Upside: +629.93%
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $6.52
Upside: -